Our work reported here showed that SOX7 expression was correlated positively with AXIN2 and negatively with β-catenin, supporting our postulated synergy of SOX7 and AXIN2 to suppress tumor progression by promoting β-catenin degradation42. The gene discussed is SOX7; the disease is neoplasm.